| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |